Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis

BACKGROUND: This study aimed to investigate the efficacy of prophylactic amifostine in reducing the risk of severe radiation colitis in cancer patients receiving radical radiotherapy to the pelvis. METHODS: Patients with pelvic tumours referred for radical radiotherapy who consented participation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanos, Konstantinos H, Briasoulis, Evangelos, Tsekeris, Pericles, Batistatou, Anna, Bai, Maria, Tolis, Christos, Capizzello, Antonio, Panelos, Ioannis, Karavasilis, Vasileios, Christodoulou, Dimitrios, Tsianos, Epameinondas V
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903531/
https://www.ncbi.nlm.nih.gov/pubmed/20537164
http://dx.doi.org/10.1186/1756-9966-29-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903531/
https://www.ncbi.nlm.nih.gov/pubmed/20537164
http://dx.doi.org/10.1186/1756-9966-29-68

Ejemplares similares